Bjørneklett Rune, Solbakken Vilde, Bostad Leif, Fismen Anne-Siri
Department of Clinical Medicine, University of Bergen, Jonas Lies vei 91b, 5021, Bergen, Norway.
Emergency Care Clinic, Haukeland University Hospital, Jonas Lies vei 65, 5021, Bergen, Norway.
Int Urol Nephrol. 2018 Jul;50(7):1311-1318. doi: 10.1007/s11255-018-1888-8. Epub 2018 May 22.
Sex-specific differences in the risk of end-stage renal disease (ESRD) in patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis (ANCA-GN) stratified by histological classification have not been previously investigated.
Patients with biopsy-verified pauci-immune necrotizing GN and positive ANCA serology in the Norwegian Kidney Biopsy Registry between 1991 and 2012 were included. Patients with ESRD during follow-up were identified from the Norwegian Renal Registry. ESRD-free survival stratified by histological classifications was investigated.
We analyzed 358 patients, of whom 87 progressed to ESRD during follow-up. Overall ESRD-free survival at 1 and 5 years in the entire cohort was 81 and 71% in males versus 90 and 80% in females, respectively; 94 and 84% in males versus 98 and 98% in females with focal histology, respectively; 85 and 76% in males versus 89 and 77% in females with mixed histology, respectively; 72 and 58% in males versus 90 and 78% in females with crescentic histology, respectively; and 52 and 46% in males versus 60 and 38% in females with sclerotic histology, respectively. Males had an increased risk of ESRD (adjusted hazard ratio, 2.44 [1.56-3.82]; p < 0.001).
Male sex is associated with increased risk of ESRD across all histological classes of ANCA-GN.
抗中性粒细胞胞浆抗体相关性肾小球肾炎(ANCA-GN)患者中,按组织学分类分层的终末期肾病(ESRD)风险的性别差异此前尚未得到研究。
纳入1991年至2012年间挪威肾脏活检登记处中经活检证实为少免疫性坏死性肾小球肾炎且ANCA血清学阳性的患者。随访期间发生ESRD的患者从挪威肾脏登记处中识别出来。研究按组织学分类分层的无ESRD生存期。
我们分析了358例患者,其中87例在随访期间进展为ESRD。整个队列中男性1年和5年的总体无ESRD生存率分别为81%和71%,女性分别为90%和80%;局灶性组织学的男性患者中分别为94%和84%,女性患者中分别为98%和98%;混合性组织学的男性患者中分别为85%和76%,女性患者中分别为89%和77%;新月形组织学的男性患者中分别为72%和58%,女性患者中分别为90%和78%;硬化性组织学的男性患者中分别为52%和46%,女性患者中分别为60%和38%。男性发生ESRD的风险增加(调整后的风险比,2.44 [1.56 - 3.82];p < 0.001)。
在ANCA-GN的所有组织学类型中,男性与ESRD风险增加相关。